COMMUNIQUÉS West-GlobeNewswire

Buying Guide -Instant female arousal pills over the counter 2025 By OhYes
25/09/2025
Women’s wellness has reached an exciting new milestone with the launch of the upgraded Oh Yes instant female arousal pills, now available over the counter. This advanced formula is designed to deliver faster, stronger, [...]
SoCalBio Investor Conference Sessions to Spotlight Bioscience Workforce Development, Technology Transfer, and AI-Driven Innovation
25/09/2025
27th Annual Conference Set for October 1–2 in Orange County Will Unite Leaders From Across the Bioscience Industry LOS ANGELES, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The Southern California Biomedical Council (SoCalBio) [...]
Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI
25/09/2025
PALO ALTO, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
Buying Guide 2025- Pills to Increase Sex Drive Female 2025 -Start Your Libido Life Today with Oh yes
25/09/2025
Women’s wellness just reached a new level with the launch of the upgraded Oh Yes instant female arousal pills over the counter. This enhanced formula is designed to provide faster, more powerful, and longer-lasting [...]
Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain
25/09/2025
VANCOUVER, British Columbia and BOSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, [...]
Cidara Therapeutics Announces First Participants Dosed in Phase 3 ANCHOR Trial Evaluating CD388 for the Prevention of Seasonal Influenza in High-Risk Populations
25/09/2025
- Phase 3 study expected to enroll 6,000 participants starting in the Northern Hemisphere - Participants will include adults over 65 years of age in addition to individuals with high-risk co-morbidities and immune [...]
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
25/09/2025
MIAMI, Sept. 25, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the [...]
Option Care Health to Announce Third Quarter 2025 Financial Results and Host Conference Call
25/09/2025
BANNOCKBURN, Ill., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today [...]
PriceMDs announced that it has entered into a senior secured credit facility of up to $20 million
25/09/2025
CLEARWATER, Fla., Sept. 25, 2025 (GLOBE NEWSWIRE) -- PriceMDs.com, Inc, an innovative healthcare technology and solutions company that significantly reduces medical costs for self-insured employers and their members, [...]
Arkansas Psychological Association Announces Fall 2025 Conference on Suicide Prevention and Mental Health
25/09/2025
Little Rock, Arkansas, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The Arkansas Psychological Association (ArPA) will host its Fall 2025 Conference , "Turning the Tide: Strengthening Hope, Connection, and Community," on October [...]
OSE Immunotherapeutics publie sa position de trésorerie au 30 juin 2025
25/09/2025
OSE Immunotherapeutics publie sa position de trésorerie au 30 juin 2025 Nantes, France – le 25 septembre 2025 à 18h00 – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnemo : OSE) publie sa position de trésorerie au [...]
OSE Immunotherapeutics publie sa position de trésorerie au 30 juin 2025
25/09/2025
OSE Immunotherapeutics Reports its Cash Position as of June 30, 2025 Nantes, France, September 25, 2025, 6 p.m. CET - OSE Immunotherapeutics SA ( ISIN: FR0012127173; Mnemo: OSE) reports its cash position as of June 30, [...]
Acıbadem Hospitals Launch “Ready for All Rounds” In‑Hospital Campaign for Breast Cancer Awareness Month
25/09/2025
Following last year’s heavy‑bag installation, this year’s activation features pink boxing gloves, a powerful reminder that early detection and multidisciplinary care help patients go the distance. ISTANBUL, Sept. 25, [...]
SciSparc Resolves to Launch Innovative Quantum Computing-Enabled 3D Protein Modeling Initiative to Revolutionize AI Drug Discovery
25/09/2025
TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat [...]
Kraig Biocraft Laboratories Successfully Completes First Parallel Two-Facility Production Cycle, Establishing Model for Continuous Recombinant Spider Silk Supply Chain
25/09/2025
ANN ARBOR, Mich., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced the successful completion of [...]
Capricor Therapeutics Provides Regulatory Update on Deramiocel Program for Duchenne Muscular Dystrophy Following Type A Meeting
25/09/2025
FDA and Capricor aligned on endpoints for HOPE-3 pivotal trial HOPE-3 pivotal trial completed; topline data expected mid-Q4 2025 to support BLA resubmission Company preparing to resubmit CRL response under the current [...]
MiNK Therapeutics Dr. Jennifer Buell to Deliver Featured Plenary at 10th Annual CAR-TCR Summit in Boston, MA
25/09/2025
NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (Nasdaq: INKT), a clinical-stage biopharmaceutical company pioneering invariant natural killer T (iNKT) cell therapies, today announced that its [...]
MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia
25/09/2025
MediWound Expands Global Reach with Marketing Approval of NexoBrid ® in Australia TGA Approves NexoBrid ® for Adults and Children; Manufacturing Readiness Positions MediWound for 2025 Launch and Asia-Pacific Expansion [...]
Annovis Appoints Mark Guerin as Chief Financial Officer
25/09/2025
MALVERN, Pa., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative [...]

Pages